Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT06409052
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Qualitative interviews — BEHAVIORALInterviews will be conducted for approximately 45-60 minutes
Study Details
To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing
Key Dates
- Start date
- Jun 25, 2024
- Status verified
- Jan 2026
- Primary completion
- Aug 3, 2026
- Completion
- Aug 3, 2026
Study Design
- Enrollment
- 45 participants (estimated)
Primary Outcome Measure
Patient education [ Time Frame: Through study completion; an average of 1 year. ]
Central Contacts
- Larissa Meyer, MD(713) 745-0973
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasPHASE1/PHASE2 · Recruiting · Novartis Pharmaceuticals · Atlanta, Georgia
- BP1001-A in Patients With Advanced or Recurrent Solid TumorsPHASE1 · Recruiting · Bio-Path Holdings, Inc. · Silver Spring, Maryland
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California